The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia

This study has been terminated.
(No more funding)
Sponsor:
Collaborators:
Rigshospitalet, Denmark
Glostrup University Hospital, Copenhagen
Pfizer
Information provided by (Responsible Party):
Birte Glenthoj, University of Copenhagen
ClinicalTrials.gov Identifier:
NCT00206947
First received: September 11, 2005
Last updated: September 19, 2011
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)